Aposcience

Hendrik Jan Leonard Ankersmit, M.D., CEO
Vienna, Austria
(Private)
Aposcience is an Austrian biopharmaceutical company headquartered in Vienna. The company has developed a proprietary, innovative therapeutic derived from white blood cells. APOSEC is the secretome of stressed leukocytes and is manufactured under GMP conditions. Batch-to-batch comparability, stability, and viral clearance were proven to regulatory authority. In December 2019 the randomized, double-blinded, multi-centre clinical Phase II trial was approved national authorities; the indication for this trial is diabetic foot ulcer.
www.aposcience.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions